Citadel Advisors’s NewGenIvf Group Warrants NIVFW Stock Holding History

Citadel Advisors’s Portfolio NIVFW Stock Details NIVFW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$581	Sell	29,346 -75	-0.3%	-$1	﹤0.01%	12846
2025 Q4	$500	Sell	29,421 -188	-0.6%	-$4	﹤0.01%	12497
2025 Q3	$489	Sell	29,609 -167	-0.6%	-$4	﹤0.01%	12612
2025 Q2	$694	Sell	29,776 -1,817	-6%	-$38	﹤0.01%	12280
2025 Q1	$569	Sell	31,593 -1,000	-3%	-$36	﹤0.01%	14242
2024 Q4	$1.46K	Sell	32,593 -169	-0.5%	-$5	﹤0.01%	14186
2024 Q3	$364	Buy	32,762 +3,550	+12%	+$115	﹤0.01%	14036
2024 Q2	$1.46K	Buy	+29,212	New	+$1.57K	﹤0.01%	13814

Other funds holding NIVFW

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors's NIVFW Position: Q1 2026 in Review

Citadel Advisors reduced its NewGenIvf Group Warrants (NIVFW) stake by 0.25% in Q1 2026, selling an estimated $1 and leaving 29,346 shares worth $581. The position accounts for ﹤0.01% of the portfolio, ranked #12846.

Citadel Advisors first reported a position in NIVFW in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.46K in Q2 2024. 13 funds tracked by Wall St. Rank hold NIVFW as of Q1 2026.

Citadel Advisors held 29,346 shares of NewGenIvf Group Warrants worth $581 as of Q1 2026.
Citadel Advisors sold 75 NewGenIvf Group Warrants shares in Q1 2026, an estimated $1.
NewGenIvf Group Warrants made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12846 holding.
Citadel Advisors first reported a position in NewGenIvf Group Warrants in Q2 2024 and has held it in 8 quarters since.
Citadel Advisors's NewGenIvf Group Warrants position peaked at $1.46K in Q2 2024.
13 funds tracked by Wall St. Rank held NewGenIvf Group Warrants as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.